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ABSTRACT
OBJECTIVE: To determine the prevalence of current depressive symptoms in people with 
diabetes mellitus and their association with the disease.
METHODS: Data were collected from the Brazilian National Health Survey (Pesquisa Nacional 
de Saúde – PNS), a cross-sectional, population-based study conducted in 2013. Study participants 
were selected by simple random cluster sampling in three stages: census tracts, households, and 
residents aged ≥ 18 years. The presence of diabetes was self-reported, whereas the presence of 
current depressive symptoms was determined by the Patient Health Questionnaire–9 (PHQ-9) 
and mean scores  of this questionnaire were calculated for the variables assessed. Tobit regression 
was used to evaluate variation in these individuals.
RESULTS: Of the 60,202 interviewees, 6.03% (n = 3,636) reported diabetes mellitus. The disease 
was more frequent in female, older, widowed, obese and with incomplete elementary education. 
Depression symptoms were mild-to-moderately severe in 22% of the diabetics. The severity of 
current depressive symptoms was higher in individuals that were female (PHQ-9 mean = 3.35), 
older adults (PHQ-9 mean = 3.01), indigenous (PHQ-9 mean = 3.46), separated/divorced (PHQ-9 
mean = 3.13), widowed (PHQ-9 mean = 3.39), obese (PHQ-9 mean = 3.13) and with incomplete 
primary education (PHQ-9 mean = 3.21). Higher severity of depressive symptoms was associated 
with the use of insulin and with coma (PHQ-9 mean = 8.32), limb amputation (PHQ-9 mean 
= 7.55), circulatory problems (PHQ-9 mean = 6.94), infarction (PHQ-9 mean = 6.83), diabetic 
foot (PHQ-9 mean = 6.62), and kidney problems (PHQ-9 mean = 6.68). The severity of current 
depressive symptoms was associated with diabetes severity and degree of limitation in activities 
of daily living (PHQ-9 mean = 10.62).
CONCLUSIONS: Interventions to improve depressive symptoms should be prioritized in 
people with diabetes are female, older adults, indigenous, widowed, separated/divorced, obese 
and with incomplete elementary education.
DESCRIPTORS: Adult. Diabetes Mellitus, epidemiology. Depression, epidemiology. Risk factors. 
Patient Health Questionnaire, utilization. Health Surveys. 
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INTRODUCTION
Diabetes is a chronic, progressive disease often associated with numerous neuropsychiatric 
comorbidities, particularly depression. The prevalence of depression is 2–3 times higher in 
patients with diabetes than in the general population1,2. Depression is considered one of 
the most overlooked symptoms in diabetics and is directly associated with a worse quality 
of life2.
According to the International Diabetes Federation, there were 382 million people with 
type 2 diabetes mellitus in 20133. Epidemiological studies in the United Nations’ countries 
found a global prevalence of diabetes of 8.3% among adults aged 20–79 years in 2011, with 
an estimated increase to 9.9% by 20304.
A systematic review showed that depression rates among people with diabetes in low- 
and middle-income countries may be higher than that in high-income countries3. 
Another systematic review of data from high-income countries indicated that 
depression contributes to increased diabetes-related comorbidities and higher health 
system costs5. Yet another showed that people with type 2 diabetes have a 24% higher 
likelihood of developing depressive symptoms in comparison to individuals without 
the disease6.
The severity of depressive episodes, dysthymia, mood disorders, and suicidal ideation is 
associated with lower quality of life, increased comorbidities, and poor diabetes control7. 
There are several obstacles to detecting cases using population-based surveys, including 
the lack of a gold standard and the high level of resources required to conduct two-step 
interviews. Consequently, validated instruments measuring depressive symptoms at the 
time of interview tend to be employed8.
A cross-sectional study evaluated the prevalence of depressive and anxiety symptoms 
together with the decline in quality of life in 210 individuals with type 1 and 2 diabetes. 
The authors found a higher prevalence of anxiety and depression in patients with type 
1 diabetes. In general, individuals with symptoms of depression and anxiety had worse 
quality of life9.
A Brazilian hospital survey of 346 individuals with type 1 and 2 diabetes demonstrated 
that patients with type 1 diabetes had a higher quality of life score than patients with type 
2 diabetes regarding mobility, self-care, performance of activities of daily living, pain and 
discomfort, and anxiety and depression10.
In Brazil, diabetes prevalence is generally estimated by health surveys based on self-reported 
measures owing to difficulties collecting biochemical data in large populations11. The 
National Health Survey (Pesquisa Nacional da Saúde – PNS) was carried out by the Brazilian 
Ministry of Health and described the health situation and lifestyles of Brazilians, as well as 
their healthcare in terms of access and use of services, preventive actions, continuity of care, 
and healthcare expenditure12. This population-based survey determined the prevalence of 
self-reported diabetes in the Brazilian population.
Data from the National Health Survey in 2013 showed that 4.1% of the Brazilian population 
currently had depressive symptoms. The authors observed that depression was more 
frequent among individuals that were female, aged ≥ 40–59 years, living in urban areas, 
less educated, smokers, hypertensive, diabetic and with heart disease13.
The mental health state of the population is an important and essential component of public 
health since depression is the most prevalent mental disorder worldwide13. In Brazil, there 
are no epidemiological studies determining the prevalence of depression among diabetic 
individuals or the factors associated with the condition. This cross-sectional study sought 
to determine the prevalence of current depressive symptoms in diabetes mellitus and their 
association with the disease.
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METHODS
Study Design
This is a cross-sectional study drawing on the National Health Survey, a population-based 
household survey with national representativeness, conducted in 2013. Self-reported 
diabetes mellitus and current depressive symptoms were the primary outcomes analyzed.
Research Site and Setting
The National Health Survey was carried out by the Brazilian Institute of Geography and 
Statistics, in collaboration with the Ministry of Health, and entailed interviews conducted 
with adults, collecting data on their health status, access to public services, participation 
in prevention activities, and lifestyles12.
Households were drawn from the master sample of the National Household Sample Survey, 
an annual survey used by the IBGE for planning Federal Government actions. This approach 
provided greater geographic coverage and improved accuracy of estimates14.
Methodological details, including the survey design and development process, have been 
described by Damacena et al.12 and Souza-Júnior et al.15
Sample Selection
The National Health Survey adopted simple randomized cluster sampling in three stages: census 
tracts, households, and residents aged ≥ 18 years14. The total sample size was 81,357 households. 
In the first stage of the random selection process, sectors with special characteristics and low 
population (indigenous, barracks, military bases, lodgings, camps, boats, penitentiaries, penal 
colonies, prisons, asylums, orphanages, convents, and hospitals) were excluded16. Thus, 81,167 
households were visited, of which 69,994 were occupied. A total of 60,202 individual interviews were 
conducted with the randomly selected residents13. For this study, interviews containing answers 
to questions about the presence of diabetes mellitus and depressive symptoms were selected.
Data Collection Procedure
The individual questionnaires were completed with the aid of handheld computers by 
interviewers previously trained by the IBGE and Ministry of Health. The results are available 
for download on the IBGE website (http://www.ibge.gov.br/home/estatistica/populacao/
pns/2013_vol3/default_microdados.shtm).
Diabetes prevalence was self-reported and addressed by the question: “Has a doctor ever diagnosed 
you with diabetes?”. The presence and severity of current depressive symptoms in the population 
with diabetes were measured by the Patient Health Questionnaire-9 (PHQ-9)17. Such questionnaire 
comprises nine questions scored as zero (no days), one (less than half the days), two (more than 
half the days) and three (almost every day). Interviewees were stratified by the severity of current 
depressive symptoms according to the PHQ-9 score: none-minimal (0–4 points), mild (5–9 points), 
moderate (10–14 points), moderately-severe (15–19 points), and severe (20–27 points).
To characterize the sample, the following information was extracted from the database: gender 
(male, female), age (18–39, 40–59, ≥ 60), ethnicity (white, black, Asian, brown, or indigenous), 
marital status (married, separated or divorced, widowed, and single), education (higher education 
or post-secondary education, secondary school, elementary school, incomplete elementary 
school), Body Mass Index - BMI (normal weight, overweight, obese), strategies used in diabetes 
treatment, habitual activities, and the severity of current depressive symptoms in the population.
Regarding treatment strategies, participants were asked whether they regularly visited 
the doctor for diabetes mellitus, received treatment guidelines, were routinely examined 
for diabetes-related complications (visual problems, infarction, stroke, other circulatory 
problems, kidney problems, diabetic foot, upper and lower limb amputation, diabetic 
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coma, and others) and whether they had been hospitalized for diabetes. Limitations in 
habitual activities due to diabetes were measured by a Likert-type scale (not limited, a 
little, moderately, severely, and very severely).
Statistical Analysis
Presence of diabetes and the PHQ-9 score were used for quantitative analyses. The 
participants’ characteristics were described using simple frequencies and stratified by the 
presence of diabetes and severity of current depressive symptoms. Treatment strategies 
frequency, the degree of limitation in habitual activities, and severity of current depressive 
symptoms were described for the diabetic population.
PHQ-9 mean values were calculated for the variables studied. Considering the ceiling effect 
of the PHQ-9 score (most people do not present depressive symptoms and have zero scores), 
Tobit regression was used to evaluate score variation in patients with diabetes. The effect 
of complex sampling was considered for all calculations and associations were regarded 
as significant when p < 0.05. Analyses were performed using the statistical program Stata 
(version 14.2). Sensitivity analysis was performed using a bootstrap technique.
Ethics Approval and Participant Consent
The National Health Survey was approved by the National Ethics Commission on July 8, 
2013, under Protocol 10853812.7.0000.0008. Adult participation in the survey was voluntary 
and the confidentiality of information was ensured, in accordance with Resolution no. 466 
of December 12, 2012, of the National Health Council.
Table 1. Sociodemographic and clinical characteristics of the Brazilian population with diabetes mellitus as a function of depressive 
symptoms. Brazil, 2013. (n = 3,636)
Variable
Population Depressive symptoms
Total
n (%)
Diabetes
n (%)
p % None-minimal
% 
Mild
% Moderate
% Moderately 
severe
% Severe p
Gender
Male 25,916 (43.0) 1,281 (6.3) 0.0025 85.43 9.85 3.00 1.14 0.58 < 0.0001
Female 34,286 (56.9) 2,355 (7.6) 73.08 16.20 6.37 2.90 1.45
Age (years)
18–39 28,722 (47.7) 315 (1.2) < 0.001 81.25 12.32 4.07 1.63 0.73 < 0.0001
40–59 20,613 (34.2) 1,425 (7.9) 76.73 14.09 5.50 2.32 1.36
≥ 60 10,866 (18.0) 1,896 (19.1) 76.81 13.86 5.33 2.76 1.25
Ethnicity*
White 28,571 (47.5) 1,556 (7.3) 0.0779 79.53 12.98 4.47 2.08 0.94 < 0.1241
Black 5,538 (9.2) 415 (8.2) 79.08 12.36 5.21 2.02 1.33
Asian 565 (0.94) 29 (6.8) 79.39 12.93 4.38 2.29 1.00
Brown 25,272 (41.9) 1,608 (6.5) 78.22 13.56 5.06 2.05 1.11
Indigenous 252 (0.4) 27 (8.5) 69.66 22.24 5.16 2.82 0.13
Marital status
Married 26,669 (44.3) 1,621 (8.3) < 0.001 79.84 12.32 4.71 2.08 1.05 < 0.0015
Separated/Divorced 3,913 (6.5) 416 (9.8) 75.30 14.67 6.09 2.43 1.51
Widowed 4,021 (6.7) 757 (17.5) 73.40 15.78 6.42 3.17 1.23
Single 25,597 (42.5) 842 (3.2) 79.33 13.50 4.40 1.83 0.94
Education*
Higher or postgraduate 9,228 (15.3) 365 (4.3) < 0.001 81.35 12.95 3.75 1.44 0.50 < 0.0001
High School 23,575 (39.2) 730 (3.8) 81.55 12.24 3.99 1.53 0.69
Elementary School 2,516 (4.2) 1,788 (9.7) 77.09 13.61 5.42 2.35 1.52
Incomplete elementary 
school
2,233 (3.7) 216 (11.5) 75.13 14.90 5.43 3.29 1.25
Body Mass Index*
Normal weight  
(18.5–25 kg/m2)
27,801 (46.2) 602 (3.8) < 0.001 80.72 12.52 4.37 1.50 0.89 < 0.0001
Overweight (≥ 25 kg/m2) 21,161 (35.1) 931 (7.5) 80.81 12.64 4.11 1.65 0.78
Obese (≥ 30 kg/m2) 11,239 (18.7) 823 (12.4) 74.98 15.02 5.94 3.06 1.00
* Not all participants responded.
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RESULTS
In a population of 60,202 respondents, 3,636 (6.03%) had diabetes. The total population 
consisted predominantly of females, individuals aged 18–39 years, white and brown, married, 
single or widowed, educated until the high school level, and non-obese.
The population with diabetes mellitus comprised predominantly individuals that were 
female, older adults, widowers, with incomplete primary education and obese. Moderately-
severe or severe current depressive symptoms were also higher in this group, although most 
had none or minimal depressive symptoms. Approximately 22.5% of participants had mild-
to-severe current depressive symptoms (Table 1).
The presence of current depressive symptoms in the population with diabetes mellitus 
was higher in women, and especially among older adults, indigenous, separated/divorced 
and widowed, obese individuals and those with incomplete primary education (Table 2).
The severity of current depressive symptoms was evaluated in relation to treatment 
strategies, duration of illness, and diabetes complications. Patients with diabetes diagnosed 
within the last two years had the greatest severity of depressive symptoms. The frequency 
of medical visits for diabetes was not associated with severity of depressive symptoms. The 
use of insulin was associated with higher severity of depressive symptoms compared with 
the use of oral medications. Mean values of the PHQ-9 were higher in individuals with coma, 
limb amputation, circulatory problems, infarction, diabetic foot, and kidney problems. The 
severity of current depressive symptoms was higher the greater the limitation in habitual 
activities caused by diabetes (Table 3).
Table 2. Variables predicting depressive symptoms in the Brazilian population with diabetes mellitus. 
Brazil, 2013. (n = 3,636)
Variable Mean PHQ-9 Coefficient p
Gender
Male 1.97 Ref
Female 3.35 2.59 < 0.001
Age (years)
18–39 2.40 Ref
40–59 2.96 0.99 < 0.001
≥ 60 3.01 1.15 < 0.001
Ethnicity
White 2.62 Ref
Black 2.74 0.19 0.351
Asian 2.64 -0.05 0.927
Brown 2.78 0.36 0.020
Indigenous 3.46 1.55 0.011
Marital status
Married 2.63 Ref
Separated/Divorced 3.13 0.91 < 0.001
Widowed 3.39 1.41 < 0.001
Single 2.60 0.00 0.991
Education
Higher or postgraduate 2.32 Ref
High School 2.34 0.05 0.739
Elementary School 2.99 1.17 < 0.001
Incomplete elementary school 3.21 1.66 < 0.001
Body Mass Index
Normal weight (18.5–24.99 kg/m2) 2.49 Ref
Overweight (≥ 25 kg/m2) 2.44 -0.19 0.171
Obese (≥ 30 kg/m2) 3.13 1.00 < 0.001
Ref: reference; PHQ-9: Patient Health Questionnaire-9
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DISCUSSION
Summary of Findings and Interpretation Based on Available Literature
In this study, one in every 16 respondents was diagnosed with diabetes mellitus, 
corresponding to approximately 6% of the population. The diabetes group comprised 
predominantly women, older adults, divorced or separated individuals with incomplete 
elementary education and obese status. Approximately 22% of the patients with diabetes 
had current depressive symptoms, whose severity was higher in women, older adults, 
indigenous, separated/divorced and widowed individuals with incomplete primary 
education and obese status.
Diabetic patients diagnosed within the last two years and in use of insulin had greater 
severity of current depressive symptoms. In addition, the presence of comorbidities (coma, 
limb amputation, circulatory problems, infarction, diabetic foot and kidney problems) was 
associated with greater severity of depressive symptoms. When the disease severely limited 
the activities of individuals with diabetes, this was also associated with a greater severity 
of depressive symptoms.
Table 3. Treatment strategies, diabetes complications, and limitation of habitual activities as a function of depressive symptoms severity in 
the population with diabetes mellitus. Brazil, 2013. (n = 3,636)
Variables 
% 
Diabetes
% None-
minimal
% 
Mild
% 
Moderate
% 
Moderately 
severe
% 
Severe
p
Mean 
PHQ-9 
PHQ-9 
Coefficient
p
Duration of illness (years)
0–2 27.8 66.7 18.1 8.9 4.4 1.9 0.8471 4.22 Ref
3–7 24.8 68.3 16.9 7.7 5.3 1.8 4.05 -0.28 0.659
8–15 23.5 67.6 19.8 6.2 3.8 2.7 3.99 -0.37 0.562
≥ 16 23.9 68.8 15.8 6.9 5.3 3.3 4.19 -0.37 0.603
Use of oral medication 75.2 68.1 17.2 7.2 5.1 2.4 0.6740 4.09 -0.19 0.712
Use of insulin 17.8 62.2 16.1 9.2 8.9 3.7 0.0082 5.25 2.03 0.002
Do you regularly visit the doctor for 
diabetes
Yes 67.7 68.1 16.98 7.28 5.18 2.46 0.3035 4.17 Ref
No (only if you have problem) 23.0 69.81 17.64 7.32 2.64 2.58 3.76 -0.73 0.223
Never visit 9.3 60.68 22.39 9.28 6.41 1.25 4.61 0.57 0.458
Complications of diabetes
Visual problems 31.9 60.3 18.5 11.0 6.1 4.1 0.0004 5.26 2.41 < 0.001
Infarction 4.3 48.4 21.2 7.3 20.5 2.6 < 0.0001 6.83 3.34 0.029
Stroke 3.9 39.9 36.3 13.5 8.4 2.0 0.0002 6.14 3.31 < 0.001
Other circulatory problems 13.7 49.6 20.4 13.2 8.8 8.1 < 0.0001 6.94 4.36 < 0.001
Kidney problem 12.3 50.2 20.5 14.3 8.8 6.2 < 0.0001 6.68 3.82 < 0.001
Diabetic foot 6.1 51.1 21.9 10.6 11.9 4.5 0.0484 6.62 3.37 0.008
Amputation of upper or lower limbs 1.6 52.7 13.2 11.0 1.3 21.8 < 0.0001 7.55 3.55 0.215
Diabetic coma 2.1 40.6 29.3 9.5 5.5 15.1 < 0.0001 8.32 5.51 0.001
Other 1.8 60.7 19.8 11.1 3.9 4.5 0.7758 5.18 1.89 0.163
Hospitalization 15.4 54.2 19.1 10.6 12.2 3.9 < 0.0001 6.19 3.34 < 0.001
Diabetes or complication of diabetes limit your habitual activities
Does not limit 66.5 75.2 15.3 5.8 2.6 1.2 < 0.0001 3.12 Ref
Limit a little 17.5 59.6 23.8 8.9 5.2 2.4 4.87 2.75 < 0.001
Moderately 9.0 54.9 21.2 9.8 9.2 4.9 5.95 4.10 < 0.001
Severely 5.1 37.1 21.3 13.1 21.6 6.9 8.80 7.15 < 0.001
Very severely 2.0 28.1 17.2 27.6 8.2 18.9 10.62 9.34 < 0.001
Ref: Reference; PHQ-9: Patient Health Questionnaire-9
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A 2016 population-based study conducted in Spain, involving 320 interviews with type 2 
diabetes mellitus, found that 27.2% had depressive symptoms (as measured by the Spanish 
version of the Beck Depression Inventory). These symptoms predominantly affected women, 
single individuals and the unemployed18; similar to the pattern observed in this study.
An observational study conducted between 2013 and 2014 in Pakistan identified the presence of 
depressive symptoms (according to PHQ-9 and the Diagnostic and Statistical Manual of Mental 
Disorders) in 133 (38.35%) patients with type 2 diabetes mellitus. Most patients were women, 
had low education, shorter time since diabetes diagnosis and obese status19. Although the 
population of the cited study was smaller than that of this investigation, the profile of patients 
was similar – female gender, low education, obesity status and a short time since diagnosis.
Another cross-sectional study evaluating the prevalence of depression in 80 patients with 
type 2 diabetes hospitalized in the south of India found that 38.75% of subjects with type 2 
diabetes were diagnosed with depression (based on the Diagnostic and Statistical Manual 
of Mental Disorders). One should note that none of the factors evaluated (age, sex, education, 
income, and marital status) had a significant influence on the occurrence of depression; 
this, according to the author, may have been due to the small sample size, which precluded 
the generalization of findings20.
A cross-sectional study carried out in Australia involving 5,462 older men with self-reported 
diabetes showed that 6.5% had depressive symptoms (according to the Geriatric Depression 
Scale – GDS15). These older individuals were nearly twice as likely to have depression 
compared with those without diabetes (OR = 1.94, 95%CI 1.15–2.48)21. Although the study 
was specifically in a male population, it demonstrated the presence of depressive symptoms 
in older adults with diabetes, a finding also observed in the Brazilian population.
In a cross-sectional study with 700 participants, conducted at three public clinics in Malaysia 
in 2013, the prevalence of any degree of depression was 41.7%, with frequent mild depressive 
symptoms in 30.6% of patients. These symptoms were more prevalent in individuals who 
were single, divorced/separated and with microvascular complications (retinopathy, 
nephropathy, and diabetic foot)22. In this study, some of the complications of diabetes (coma, 
limb amputation, circulatory problems, infarction, and the presence of diabetic foot and 
kidney problems) were also associated with increased severity of depressive symptoms.
A cross-sectional multicenter study carried out at four outpatient clinics in Pakistan included 
889 adults with type 2 diabetes. Approximately 43% of the participants had depression, 
and this condition was significantly associated with being female, older, having ischemic 
heart disease and obese status23. Such result was similar to the findings of this study, with 
depression being found predominantly in females, older adults, and obese participants.
Many studies, including systematic reviews, have found that people at risk of having diabetes 
and diabetics have more depressive symptoms compared with non-diabetics24,25, and the 
literature has shown depression is a risk factor for developing diabetes. A systematic review 
observed that depressed individuals have a 41% greater risk for developing diabetes mellitus 
and a 32% greater risk for developing type 2 diabetes. However, the authors noted that the 
mechanisms underlying this relationship remain unclear and warrant further research26.
A study conducted in Romania with 1,171 diabetic patients, using the PHQ-9 and the 
Diabetes Costs Questionnaire (DCQ), assessed direct and indirect costs related to diabetes. 
This study showed statistically significant higher diabetes-related costs for patients with 
severe or mild depression than for patients without depressive symptoms27.
It is important emphasize that published data, also based on the National Health Survey 
(2013), showed that 4.1% of the Brazilian population had current depressive symptoms13, a 
lower prevalence than the rate found in the Brazilian population with diabetes; confirming 
the findings of the literature and showing the negative impact of diabetes on the living of 
the Brazilian population.
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Validity of the Study: Limitations and Strengths
Due to the cross-sectional design of this study, home interviews have been biased by 
including only participants who were at home at the time of data collection. In addition, 
it should be considered that depressed patients might be less interviewed, leading to 
underestimation of the association found.
On the other hand, the sample size is a strength of this study. The National Health Survey is 
a nationwide, community-based epidemiological survey that includes Federal and capital 
units, metropolitan areas, and the rest of the Federal units in the country. This study was 
based on the master sample of such system, which provided wide geographical coverage 
and improved the accuracy of estimates14,16.
Some methodological limitations inherent to prevalence studies, and the fact that diabetes 
mellitus was self-reported, may have led to disease underdiagnoses. The data was therefore 
insufficient for allowing diabetes to be categorized. However, for a survey of this magnitude, 
it is impractical to collect data in two steps to confirm the diagnosis.
In addition, the use of a validated instrument to assess depressive symptoms (PHQ-9) 
demonstrates the care taken in devising the questionnaire. However, it should be pointed 
out that the measure of depressive symptoms was based on the 2-week period leading up 
to interview and, therefore, provides only a current prevalence of depression. Lastly, it is 
important to emphasize that the prevalence of depression reported by studies may vary 
owing to differences in assessment methods (self-reported, screening instruments, clinical 
diagnosis etc.), sample type (population-based, hospital in-patients etc.), among other factors.
Implications for Clinical Practice and Research
Cross-sectional studies are important for collecting up-to-date information on the 
population with diabetes and can aid health service planning and future research. In this 
respect, this study is important given the absence of electronic databases containing this 
much-needed information.
The creation of strategies to improve depressive symptoms in individuals with diabetes 
mellitus should prioritize women, older individuals indigenous, widowed, separated/
divorced, obese and with incomplete elementary education.
The information yielded by this study may contribute to a better understanding of depression 
and its associated factors in the Brazilian population with diabetes mellitus and help guide 
initiatives and programs promoting care in this group of patients.
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